세포주 개발 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상되며, 2029년까지 연평균 14.7%의 복합 성장률(CAGR)로 163억 3,000만 달러에 달할 것으로 예측됩니다. 예측 기간의 성장은 암 유병률 증가, 만성질환 유병률 증가, 헬스케어에 대한 정부 투자 증가에 기인합니다. 예측 기간의 주요 동향으로는 제휴, 투자, 제품 혁신 등이 있습니다.
예상되는 암 유병률 증가가 당분간 세포주 개발의 성장을 견인할 것입니다. 암은 체내 비정상 세포의 무질서한 증식과 확산을 특징으로 하는 질병군을 말합니다. 암 환자 증가는 주로 인구 증가, 고령화, 생활습관 선택, 비만, 유전적 소인 등의 요인에 기인합니다. 세포주는 만성질환 치료에 효과적인 약물을 선별하기 위한 중요한 도구입니다. 연구자들은 이러한 세포주를 다양한 화합물에 노출시키고 그 효과를 관찰함으로써 추가 개발을 위한 유망한 약물 후보를 쉽게 식별할 수 있습니다. 예를 들어, 세계보건기구(WHO)가 2024년 2월에 발표한 보고서에 따르면, 2050년까지 새로운 암 환자 수는 3,500만 명 이상에 달할 것으로 예상되며, 이는 2022년 추정치인 2,000만 명에서 77% 증가한 수치입니다. 이처럼 암 유병률 증가는 세포주 개발 시장의 기폭제가 되고 있습니다.
세포주 개발 시장의 주요 업체들은 경쟁 우위를 확보하기 위해 혁신적인 플랫폼을 적극적으로 추구하고 있습니다. 이러한 혁신적인 플랫폼은 세포주 개발 프로세스를 간소화하고 최적화하여 생물학적 의약품 개발을 지원하는 속도, 효율성 및 생산성 향상을 제공하는 능력으로 두드러집니다. 예를 들어, 2023년 1월 영국에 본사를 둔 연구, 개발 및 제조 아웃소싱 서비스 제공업체인 앱제나는 생물학적 제제 프로그램의 세포주 개발(CLD) 프로세스를 가속화하기 위해 설계된 새로운 플랫폼인 'AbZelect'와 'AbZelectPro'를 발표하였습니다. 발표했습니다. 이 플랫폼은 생산성을 향상시켜 한 번의 생산 공정에서 더 많은 원료의약품을 생산할 수 있게 해줍니다. 이러한 효율성 향상은 고객의 생산 능력을 확장하고 비용을 절감할 뿐만 아니라, 필요한 환자에게 중요한 치료제를 더 빨리 제공할 수 있도록 돕습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 세포주 개발 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 세포주 개발 시장 : 성장률 분석
- 세계의 세포주 개발 시장 실적 : 규모와 성장, 2019-2024
- 세계의 세포주 개발 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 세포주 개발 전체 시장(TAM)
제6장 시장 세분화
- 세계의 세포주 개발 시장 : 제품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 시약 및 배지
- 장비
- 액세서리 및 소모품
- 세계의 세포주 개발 시장 : 소스별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 포유류
- 비포유류
- 세계의 세포주 개발 시장 : 세포주별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 재조합
- 잡종 세포
- 상용 세포주
- 1차 세포주
- 세계의 세포주 개발 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 바이오프로덕션
- Drug Discovery
- 독성 시험
- 조직공학
- 조사
- 세계의 세포주 개발 시장 : 시약 및 배지 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세포배양 배지
- 무혈청 배지
- 재조합 단백질 보충제
- 성장인자
- 사이토카인 및 호르몬
- 완충제 및 소금
- 세계의 세포주 개발 시장 : 기기별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 바이오리액터 및 발효조
- 인큐베이터
- 세포 카운터 및 분석 장비
- 세포 선별 장비
- 동결보존 장비
- 여과 및 분리 장비
- 세계의 세포주 개발 시장 : 액세서리 및 소모품 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 배양 용기(플라스크, 플레이트)
- 피펫트 및 피펫트팁
- 세포배양 인서트
- 주사기 및 바늘
- 냉동 배양기 및 냉동 용기
- 페트리 접시
제7장 지역별/국가별 분석
- 세계의 세포주 개발 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 세포주 개발 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 세포주 개발 시장 : 경쟁 구도
- 세포주 개발 시장 : 기업 개요
- Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- GE Health Care Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- AGC Biologics
- Corning Inc.
- Eurofins Scientific
- Lonza Pvt. Ltd.
- WuXi App tech
- Sartorius AG
- GenScript Biotech Corporation
- FUJIFILM Diosynth Biotechnologies
- Promega corporation
- KBI Biopharma Inc.
- Rentschler Biopharma SE
- Advanced Instruments LLC
- Cyagen
- Horizon Discovery Group Plc
- Probiogen AG
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 세포주 개발 시장(2029년) : 새로운 기회를 제공하는 국가
- 세포주 개발 시장(2029년) : 새로운 기회를 제공하는 부문
- 세포주 개발 시장(2029년) : 성장 전략
제36장 부록
LSH
Cell line development involves the creation of immortalized cell cultures derived from specific cell types, often originating from a particular organism or tissue. These cell lines are nurtured under controlled laboratory conditions and can be perpetually cultivated and reproduced.
The primary product types associated with cell line development include reagents and media, equipment, accessories, and consumables. Reagents and media encompass essential components utilized in laboratory settings for diverse biological and chemical analyses, experiments, and procedures. These components are sourced from various organisms, including mammalian and non-mammalian, and are utilized to generate different types of cell lines such as recombinant, hybridomas, continuous cell lines, and primary cell lines. Applications for these cell lines span bioproduction, drug discovery, toxicity testing, tissue engineering, and research endeavors.
The cell line development market research report is one of a series of new reports from The Business Research Company that provides cell line development market statistics, including cell line development industry global market size, regional shares, competitors with a cell line development market share, detailed cell line development market segments, market trends, and opportunities, and any further data you may need to thrive in the cell line development industry. This cell line development research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cell line development market size has grown rapidly in recent years. It will grow from $8.21 billion in 2024 to $9.44 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased vaccine production, increased aging population, and increased clinical trials.
The cell line development market size is expected to see rapid growth in the next few years. It will grow to $16.33 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to increasing prevalence of cancer, increasing prevalence of chronic diseases, increasing government investments in healthcare. Major trends in the forecast period include partnerships, investments, and product innovations.
The anticipated rise in cancer prevalence is poised to drive the growth of cell line development in the foreseeable future. Cancer refers to a group of diseases characterized by the uncontrolled proliferation and spread of abnormal cells within the body. The increase in cancer cases is attributed primarily to factors such as population growth, aging, lifestyle choices, obesity, and genetic predisposition. Cell lines serve as crucial tools for screening potential drugs for their efficacy in treating chronic diseases. Researchers expose these cell lines to various compounds and observe their effects, facilitating the identification of promising drug candidates for further development. For instance, according to the World Health Organization's February 2024 report, the projected number of new cancer cases is expected to reach over 35 million by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Thus, the growing prevalence of cancer serves as a catalyst for the cell line development market.
Key players in the cell line development market are actively pursuing innovative platforms to gain a competitive advantage. These innovative platforms are distinguished by their ability to streamline and optimize the cell line development process, offering speed, efficiency, and enhanced productivity to support the development of biological drugs. For example, in January 2023, Abzena, a UK-based company providing outsourced research, development, and manufacturing services, introduced new platforms named AbZelect and AbZelectPro, designed to accelerate the cell line development (CLD) process for biologic drug programs. These platforms enhance productivity, enabling the production of greater quantities of drug substances per manufacturing run. This heightened efficiency not only expands capacity and reduces costs for customers but also expedites the delivery of critical therapies to patients in need.
In October 2022, Cytiva, a US-based life sciences company, acquired CEVEC Pharmaceuticals for an undisclosed sum. This acquisition bolsters Cytiva's capabilities in biomanufacturing solutions and supports the company's expansion in the genomic medicine sector. CEVEC Pharmaceuticals, headquartered in Germany, specializes in high-performance cell line development and viral vector manufacturing technologies.
Major companies operating in the cell line development market are Thermo Fisher Scientific Inc., Novartis AG, Danaher Corporation, Merck KGaA, GE Health Care, AGC Biologics, Corning Inc., Eurofins Scientific, Lonza Pvt. Ltd., WuXi App tech, Sartorius AG, GenScript Biotech Corporation, FUJIFILM Diosynth Biotechnologies, Promega corporation, KBI Biopharma Inc., Rentschler Biopharma SE, Advanced Instruments LLC, Cyagen, Horizon Discovery Group Plc, Probiogen AG, PromoCell GmbH, Premas Biotech, Imgenex, NAEJA RGM Pharmaceuticals Inc
North America was the largest region in the cell line development market in 2024. The regions covered in the cell line development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cell line development market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cell line development market consists of sales of primary cell lines, immortalized cell lines, stable cell lines, and clonal cell lines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cell Line Development Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cell line development market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cell line development ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell line development market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product: Reagents And Media; Equipment; Accessories And Consumables
- 2) By Source: Mammalian; Non-Mammalian
- 3) By Cell Line: Recombinant; Hybridomas; Continuous Cell Line; Primary Cell Line
- 4) By Application: Bioproduction; Drug Discovery; Toxicity Testing; Tissue Engineering; Research
- Subsegments:
- 1) By Reagents And Media: Cell Culture Media; Serum-Free Media; Recombinant Protein Supplements; Growth Factors; Cytokines And Hormones; Buffers And Salts
- 2) By Equipment: Bioreactors And Fermenters; Incubators; Cell Counters And Analyzers; Cell Sorters; Cryopreservation Equipment; Filtration And Separation Equipment
- 3) By Accessories And Consumables: Culture Vessels (Flasks, Plates); Pipettes And Pipette Tips; Cell Culture Inserts; Syringes And Needles; Cryovials And Freezing Containers; Petri Dishes
- Companies Mentioned: Thermo Fisher Scientific Inc.; Novartis AG; Danaher Corporation; Merck KGaA; GE Health Care
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Cell Line Development Market Characteristics
3. Cell Line Development Market Trends And Strategies
4. Cell Line Development Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Cell Line Development Growth Analysis And Strategic Analysis Framework
- 5.1. Global Cell Line Development PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Cell Line Development Market Growth Rate Analysis
- 5.4. Global Cell Line Development Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Cell Line Development Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Cell Line Development Total Addressable Market (TAM)
6. Cell Line Development Market Segmentation
- 6.1. Global Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Reagents And Media
- Equipment
- Accessories And Consumables
- 6.2. Global Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Mammalian
- Non-Mammalian
- 6.3. Global Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Recombinant
- Hybridomas
- Continuous Cell Line
- Primary Cell Line
- 6.4. Global Cell Line Development Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bioproduction
- Drug Discovery
- Toxicity Testing
- Tissue Engineering
- Research
- 6.5. Global Cell Line Development Market, Sub-Segmentation Of Reagents And Media, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cell Culture Media
- Serum-Free Media
- Recombinant Protein Supplements
- Growth Factors
- Cytokines And Hormones
- Buffers And Salts
- 6.6. Global Cell Line Development Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bioreactors And Fermenters
- Incubators
- Cell Counters And Analyzers
- Cell Sorters
- Cryopreservation Equipment
- Filtration And Separation Equipment
- 6.7. Global Cell Line Development Market, Sub-Segmentation Of Accessories And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Culture Vessels (Flasks, Plates)
- Pipettes And Pipette Tips
- Cell Culture Inserts
- Syringes And Needles
- Cryovials And Freezing Containers
- Petri Dishes
7. Cell Line Development Market Regional And Country Analysis
- 7.1. Global Cell Line Development Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Cell Line Development Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Cell Line Development Market
- 8.1. Asia-Pacific Cell Line Development Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cell Line Development Market
- 9.1. China Cell Line Development Market Overview
- 9.2. China Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cell Line Development Market
- 10.1. India Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cell Line Development Market
- 11.1. Japan Cell Line Development Market Overview
- 11.2. Japan Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cell Line Development Market
- 12.1. Australia Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cell Line Development Market
- 13.1. Indonesia Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cell Line Development Market
- 14.1. South Korea Cell Line Development Market Overview
- 14.2. South Korea Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cell Line Development Market
- 15.1. Western Europe Cell Line Development Market Overview
- 15.2. Western Europe Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cell Line Development Market
- 16.1. UK Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cell Line Development Market
- 17.1. Germany Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cell Line Development Market
- 18.1. France Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cell Line Development Market
- 19.1. Italy Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cell Line Development Market
- 20.1. Spain Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cell Line Development Market
- 21.1. Eastern Europe Cell Line Development Market Overview
- 21.2. Eastern Europe Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cell Line Development Market
- 22.1. Russia Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cell Line Development Market
- 23.1. North America Cell Line Development Market Overview
- 23.2. North America Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cell Line Development Market
- 24.1. USA Cell Line Development Market Overview
- 24.2. USA Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Cell Line Development Market
- 25.1. Canada Cell Line Development Market Overview
- 25.2. Canada Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Cell Line Development Market
- 26.1. South America Cell Line Development Market Overview
- 26.2. South America Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Cell Line Development Market
- 27.1. Brazil Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Cell Line Development Market
- 28.1. Middle East Cell Line Development Market Overview
- 28.2. Middle East Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Cell Line Development Market
- 29.1. Africa Cell Line Development Market Overview
- 29.2. Africa Cell Line Development Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Cell Line Development Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Cell Line Development Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Cell Line Development Market Competitive Landscape And Company Profiles
- 30.1. Cell Line Development Market Competitive Landscape
- 30.2. Cell Line Development Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GE Health Care Overview, Products and Services, Strategy and Financial Analysis
31. Cell Line Development Market Other Major And Innovative Companies
- 31.1. AGC Biologics
- 31.2. Corning Inc.
- 31.3. Eurofins Scientific
- 31.4. Lonza Pvt. Ltd.
- 31.5. WuXi App tech
- 31.6. Sartorius AG
- 31.7. GenScript Biotech Corporation
- 31.8. FUJIFILM Diosynth Biotechnologies
- 31.9. Promega corporation
- 31.10. KBI Biopharma Inc.
- 31.11. Rentschler Biopharma SE
- 31.12. Advanced Instruments LLC
- 31.13. Cyagen
- 31.14. Horizon Discovery Group Plc
- 31.15. Probiogen AG
32. Global Cell Line Development Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Cell Line Development Market
34. Recent Developments In The Cell Line Development Market
35. Cell Line Development Market High Potential Countries, Segments and Strategies
- 35.1 Cell Line Development Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Cell Line Development Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Cell Line Development Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
